Member Info for Dr_Horrible

I’d forget about them and check them again in 2 years.

It’s slowly collapsing like a flan in a cupboard.

I would think at least 6 months, so Feb / March at the earliest. They will only order when it is approved and it will take time to get the goods ready for a launch.

What about existing DSM customers/prospective customers? I think the RNS' imply that the existing DSM setup for platelet aggregation is expected to bring significant multiples of current total FF sales.

Https://big5.huaxia.com/c/2023/10/25/1813285.shtml

Byhealth Co., Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 7,782.28 million compared to CNY 6,159.88 million a year ago. Revenue was CNY 7,782.28 million compared to CNY 6,159.88 million a year ago.

Https://www.marketscreener.com/quote/stock/BYHEALTH-CO-LTD-11367191/news/Byhealth-Co-Ltd-Reports-Earnings-Results-for-the-Nine-Months-Ended-September-30-2023-45135940/

And on the DSM side of things, the prospective sales pipeline remains at substantial multiples of current income. To me that means there are 1 or 2 major players planning to launch based on platelet aggregation claim. Then we have interest from ‘truly global’ for gut modulation. Can’t imagine anything happening on that for a while due to patent and general slowness.

Nothing ever happens, nothing happens at all

The needle returns to the start of the song

And we all sing along like before

and we'll be pixies tonight and pixies tomorrow

Actually, scrap that. It’s not the same article at all.

It’s been quite wide spread that one, I keep seeing it on different outlets each day.

Https://m.163.com/dy/article/IH6IBEOG0552ADWT.html?spss=adap_pc

Risks: "unexpected opportunities to develop additional products or acquire additional technologies"

Science in Sport are looking for a buyer..... :)

Terrible results. £354k in 9 months (74+280) with another £155k in the pipeline this year. So that will be about £509k (74+280+155) income in a full calendar year, with a good portion of that going to DSM.

That means BH order will potentially be multiple of not much.

Will we break even?

- no trade in jan, possibly part of Feb too

- loss due to lockdowns

- majority of customers transferred, not all.

We should see a some revenue increase, but not sure we’ll break even for year 22/23. Only 1 day until we find out.

The first sales were not until some time in Feb?. So we will only get some Feb and all March on the new structure. Then I am not confident that they will split that out in the results and if they do it will be a bit meaningless. Hopefully we get some good news, but I think December is where we can start to make sense of their forecasts. I think the Friday RNS will be more of the same, but hope I am wrong.

I suspect it will be more of the same. December is where we get a better understanding, as it will be a full 6 months on the new structure. That means that terms like 'multiple' and 'significant multiples' start to gain some meaning.

We should move into small profit without China.

1) Jan 23 - increase in profit share (step 1) and removal of DSM overheads charges.

2) Jan 23 onwards - direct customers (we hope)

3) Jan 24 - increase profit share (step 2/4)

Https://www.youtube.com/watch?v=1j9rcFLDARI

It's a good Conclusion to the Patent application.

In conclusion, under the experimental condition, the water-soluble tomato concentrate has remarkable repairing effect on rat MCAO/R injury, can remarkably reduce cerebral infarction area, reduce nerve function score, improve brain tissue pathology and increase cerebral blood flow on the side of ischemia.